Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.

TFP up for sale

HBI hears UK-based pan-European fertility group TFP is up for sale, and speaks to two well-placed sources to find out more.

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?

HBI 2021: Data drives efficiencies in healthcare systems

AI is not the be-all and end-all of efficiency in healthcare, a more basic automation and understanding of data can drive 10%+ savings. However, payors must be prepared to share some of this with their partners.

Consortium buys German lab group amedes

German lab group amedes is selling to a consortium including Canada's OMERS Infrastructure, Goldman Sachs Asset Management, and asset manager AXA Investment Managers.

Sovereign wealth funds big Asia-Pacific plays

Sovereign wealth funds are making some big entrances and exits in the Asia-Pacific with bids closing in QIC-owned oncology player Icon Group and Singapore's GIC acquiring a minority stake in Sunway hospital group Sunway Healthcare.

Social care job applications drop as economies open

Job applications for social care have dropped off a cliff in the UK as the economy starts to open up, according to an operator. Groups in Germany, France, the Netherlands and Austria say they are still seeing a surge.

Find Us